The mechanism of molecular redundancy in autoimmune inflammation in the context of CD44 deficiency

Annals of the New York Academy of Sciences

Volumn 1050, Issue , 2005, Pages 52-63

  Naor, David ^a   Nedvetzki, Shlomo ^a   Assayag, Nathalie ^a   Thurmond, Robin L ^b   Huang, Jing Feng ^b   Turley, Eva A ^c  

^a HEBREW UNIVERSITY   (Israel)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

CD44; Collagen; Gene; Inflammation; Molecular redundancy

Indexed keywords

COLLAGEN; HERMES ANTIGEN;

ARTHRITIS; AUTOIMMUNITY; CELL TRANSPORT; CONFERENCE PAPER; DNA DAMAGE; GENE LOSS; INFLAMMATION; KNOCKOUT MOUSE; LIGAND BINDING; MOLECULAR GENETICS; MOLECULAR REDUNDANCY; MULTIGENE FAMILY; NONHUMAN;

EID: 23744486993     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1313.007     Document Type: Conference Paper

References (55)

1. COOKE, J., M.A. NOWAK, M. BOERLIJST & J. MAYNARD-SMITH. 1997. Evolutionary origins and maintenance of redundant gene expression during metazoan development. Trends Genet. 13: 360-364.
2. NOWAK, M.A., M. BOERLIJST, J. COOKE & J.M. SMITH. 1997. Evolution of genetic redundancy. Nature 10: 167-171.
3. OZAKI, K. & W.J. LEONARD. 2002. Cytokine and cytokine receptor pleiotropy and redundancy. J. Biol. Chem. 277: 29355-29358.
4. HADDAD, J.J. 2002. Cytokines and related receptor-mediated signaling pathways. Biochem. Biophys. Res. Commun. 297: 700-713.
5. ZLOTNIK, A. & O. YOSHIE. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127.
6. HOWARD, O.M., J.A. TURPIN, R. GOLDMAN & W.S. MODI. 2004. Functional redundancy of the human CCL4 and CCL4L1 chemokine genes. Biochem. Biophys. Res. Commun. 30: 927-931.
7. NAKAMURA, T., K. SUGINO, K. TITANI & H. SUGINO. 1991. Follistatin, an activin-binding protein, associates with heparan sulfate chains of proteoglycans on follicular granulosa cells. J. Biol. Chem. 266: 19432-19437.
8. HEMMATI-BRIVANLOU, A., O.G. KELLY & D.A. MELTON. 1994. Follistatin, an antagonist of activin, is expressed in the Spemann organizer and displays direct neuralizing activity. Cell 77: 283-295.
9. LAMB, T.M. et al. 1993. Neural induction by the secreted polypeptide noggin. Science 262: 713-718.
10. ZIMMERMAN, L.B., J.M. DE JESUS-ESCOBAR & R.M. HARLAND. 1996. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86: 599-606.
11. SASAI, Y., B. LU, H. STEINBEISSER & E.M. DE ROBERTIS. 1995. Regulation of neural induction by the Chd and Bmp-4 antagonistic patterning signals in Xenopus. Nature 376: 333-336.
12. PICCOLO, S., B. LU, Y. SASAI & E.M. DE ROBERTIS. 1996. Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell 86: 589-598.
13. BIEHS, B., V. FRANCOIS & E. BIER. 1996. The Drosophila short gastrulation gene prevents Dpp from autoactivating and suppressing neurogenesis in the neuroectoderm. Genes Dev. 10: 2922-2934.
14. MATZUK, M.M. et al. 1995. Multiple defects and perinatal death in mice deficient in follistatin. Nature 374: 360-363.
15. MCMAHON, J.A. et al. 1998. Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes Dev. 12: 1438-1452.
16. BACHILLER, D. et al. 2003. The role of chordin/Bmp signals in mammalian pharyngeal development and DiGeorge syndrome. Development 130: 3567-3578.
17. BACHILLER, D. et al. 2000. The organizer factors Chordin and Noggin are required for mouse forebrain development. Nature 403: 658-661.
18. Li, E. et al. 1993. Normal development and growth of mice carrying a targeted disruption of the alpha 1 retinoic acid receptor gene. Proc. Natl. Acad. Sci. USA 90: 1590-1594.
19. LUFKIN, T. et al. 1993. High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. Proc. Natl. Acad. Sci. USA 90: 7225-7229.
20. MENDELSOHN, C. et al. 1994. Retinoic acid receptor beta 2 (RAR beta 2) null mutant mice appear normal. Dev. Biol. 166: 246-258.
21. LOHNES, D. et al. 1993. Function of retinoic acid receptor gamma in the mouse. Cell 73: 643-658.
22. GORRY, P. et al. 1994. The cellular retinoic acid binding protein I is dispensable. Proc. Natl. Acad. Sci. USA 91: 9032-9036.
23. LOWELL, C.A., P. SORIANO & H.E. VARMUS. 1994. Functional overlap in the src gene family: inactivation of hck and fgr impairs natural immunity. Genes Dev. 8: 387-898.
24. STEIN, P.L., H. VOGEL & P. SORIANO. 1994. Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. Genes Dev. 8: 1999-2007.
25. UMANOFF, H., W. EDELMANN, A. PELLICER & R. KUCHERLAPATI. 1995. The murine N-ras gene is not essential for growth and development. Proc. Natl. Acad. Sci. USA 92: 1709-1713.
26. COLUCCI-GUYON, E. et al. 1994. Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell 79: 679-694.
27. GOMI, H. et al. 1995. Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. Neuron 14: 29-41.
28. PEKNY, M. et al. 1995. Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J. 14: 1590-1598.
29. STEINDLER, D.A. et al. 1995, Tenascin knockout mice: barrels, boundary molecules, and glial scars. J. Neurosci. 15: 1971-1983.
30. ROSATI, R. et al. 1994. Normal long bone growth and development in type X collagen-null mice. Nat. Genet. 8: 129-135.
31. NAOR, D. et al. 2002. CD44 in cancer. Crit. Rev. Clin. Lab. Sci. 39: 527-579.
32. LESLEY, J., R. HYMAN & P.W. KINCADE. 1993. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54: 271-335.
33. NAOR, D., R. VOGT SIONOV & D. ISH-SHALOM. 1997. CD44: structure, function, and association with the malignant process. Adv. Cancer Res. 71: 241-319.
34. TAMMI, M.I., A.J. DAY & E.A. TURLEY. 2002. Hyaluronan and homeostasis: a balancing act. J. Biol. Chem. 277: 4581-4584.
35. DEGRENDELE, H.C., M. KOSFISZER, P. ESTESS & M.H. SIEGELMAN. 1997. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J. Immunol. 159: 2549-2553.
36. MOHAMADZADEH, M. et al. 1998. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J. Clin. Invest. 101: 97-108.
37. DAY, A. J. & G.D. PRESTWICH. 2002. Hyaluronan-binding proteins: tying up the giant. J. Biol. Chem. 277: 4585-4588.
38. ZHANG, S. et al. 1998. The hyaluronan receptor RHAMM regulates extracellular-regulated kinase. J. Biol. Chem. 273: 11342-11348.
39. AKIYAMA, Y. et al. 2001. Hyaluronate receptors mediating glioma cell migration and proliferation. J. Neuro-Oncol. 53: 115-127.
40. LYNN, B.D., E.A. TURLEY & J.I. NAGY. 2001. Subcellular distribution, calmodulin interaction, and mitochondrial association of the hyaluronan-binding protein RHAMM in rat brain. J. Neurosci. Res. 65: 6-16.
41. TURLEY, E.A., P.W. NOBLE & L.Y.W. BOURGUIGNON. 2002. Signaling properties of hyaluronan receptors. J. Biol. Chem. 277: 4589-4592.
42. MOHAPATRA, S. et al. 1996. Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression. J. Exp. Med. 183: 1663-1668.
43. CHEUNG, W.F., T.F. CRUZ & E.A. TURLEY. 1999. Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors. Biochem. Soc. Trans. 27: 135-142.
44. NEDVETZKI, S. et al. 1999. CD44 involvement in experimental collagen-induced arthritis (CIA). J. Autoimmun. 13: 39-47.
45. WEISS, L. et al. 2000. Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. Proc. Natl. Acad. Sci. USA 97: 285-290.
46. NEDVETZKI, S. et al. 2004. RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy. Proc. Natl. Acad. Sci. USA 101: 18081-18086.
47. ZAHALKA, M.A. et al. 1995. Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. J. Immunol. 154: 5345-5355.
48. WALLACH-DAYAN, S.B. et al. 2001. CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes. J. Cell Sci. 114: 3463-3477.
49. SCHMITS, R. et al. 1997. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 90: 2217-2233.
50. PROTIN, U., T. SCHWEIGHOFFER, W. JOCHUM & F. HILBERG. 1999. CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. J. Immunol. 163: 4917-4923.
51. STOOP, R. et al. 2001. Increased resistance to collagen-induced arthritis in CD44-deficient DBA/1 mice. Arthritis Rheum. 44: 2922-2931.
52. BONAVENTURE, P. et al. 2002. Nuclei and subnuclei gene expression profiling in mammalian brain. Brain Res. 943: 38-47.
53. SHAW, K.J. et al. 2003. Comparison of the changes in global gene expression of Escherichia coli induced by four bactericidal agents. J. Mol. Microbiol. Biotechnol. 5: 105-122.
54. KNUDSON, W., G. CHOW & C.B. KNUDSON. 2002. CD44-mediated uptake and degradation of hyaluronan. Matrix Biol. 21: 15-23.
55. TEDER, P., et al. 2002. Resolution of lung inflammation by CD44. Science 296: 155-158.